公司資料
Tactile Systems Technology, Inc. 股價、新聞與催化劑
- 股票代碼:
- TCMD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
24.59 USD (+1.61%)
收盤價
最後更新: 2026年8月17日
551M USD
市值
股價為何變動
As of Aug 17, 2026, TCMD closed up 1.61% at $24.59. No new same-company headline was identified in the current news window.
公司概覽
At-Home Chronic-Care Therapies
Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans.
Lymphedema Portfolio
The company's Flexitouch systems deliver pneumatic compression therapy for lymphedema and related swelling disorders. Its acquisition of LymphaTech broadens the portfolio across the lymphedema-care continuum with measurement and monitoring capabilities.
Airway Clearance
AffloVest is a wearable high-frequency chest-wall oscillation system used by patients with chronic respiratory conditions who need airway-clearance therapy. A next-generation system expands Tactile Medical beyond its core lymphedema franchise.
Compression and Distribution
Tactile Medical also distributes complementary products such as the MyoSleeve wearable compression device. Its commercial model combines direct patient support, clinician engagement, reimbursement services and relationships with government and private payers.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。